Skip directly to content

Court deals setback to hospital 340B drug discounts

on Tue, 05/27/2014 - 16:17

The pharmaceutical industry scored another victory Friday in its battle to limit access to lower-priced drugs through HHS' 340B drug discount program.  A U.S. district court judge ruled rural and cancer hospitals participating in 340B program could not buy high-priced orphan drugs at discounted prices if the drugs were being used off-label, according to Drug Discount Monitor, the newsletter of the Safety Net Hospitals for Pharmaceutical Access.  A rule issued by HHS in 2013 said providers had to pay the higher prices—which can range up to $300,000 a year for rare-disease drugs—when treating patients who had those diseases, but not when used off-label for more common conditions. Drug company clinical research conducted after a drug receives orphan designation from the Food and Drug Administration sometimes shows it has much wider application than its original indication.

Read More

Comments

Antonion's picture

300k $ huge amount

http://smmhouse.com buy real youtube views

Mina12's picture

The information you made is a good idea. Bath in the fame!
visit my weblog:

soundcloud favorites

buysoundcloudnow.com

angeljulie3's picture

Drug is very bad thing for all the humans, but some people are adticted to take drug to live.

Chris Evans Steve Rogers costume

sesh's picture

Taking drugs can destroy your life and mind..Thanks for sharing this great thoughts of us.

"http://buildmyviews.org/worldwide-views/"buy real youtube views